GlassScriptPhysician profile
Carol L Huang
NPI 1710931423
$29,820.94
in general payments reported to CMS, 2019-2025
31 companies · $6,551 in 2025
The $6,551 reported for 2025 was more than what 91% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,364 · 2020: $1,197 · 2021: $2,054 · 2022: $3,719 · 2023: $7,537 · 2024: $7,400 · 2025: $6,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $9,093 · Travel and Lodging: $724 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,481.91 |
| Consulting Fee | $9,092.50 |
| Travel and Lodging | $723.90 |
| Education | $189.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $5,010.58 | 2023-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $4,056.39 | 2022-2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $3,534.61 | 2023-2025 | Zoryve |
| Abbvie INC. | $2,716.54 | 2019-2025 | |
| Janssen Biotech, INC. | $2,015.93 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Genzyme Corporation | $1,509.89 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,390.52 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,292.54 | 2019-2025 | Ilumya, Winlevi, Absorica Ld |
| Lilly USA, LLC | $1,256.74 | 2019-2025 | Olumiant, Taltz, Ebglyss |
| Ucb, INC. | $1,189.45 | 2021-2025 | Bimzelx, Cimzia |
| Incyte Corporation | $1,037.21 | 2021-2025 | Opzelura |
| Pfizer INC. | $944.48 | 2019-2025 | |
| Galderma Laboratories, L.P. | $828.57 | 2019-2025 | Nemluvio, Epsolay, Oracea |
| Regeneron Healthcare Solutions, INC. | $732.18 | 2020-2025 | Dupixent |
| Leo Pharma INC. | $640.11 | 2019-2025 | Adbry, Anzupgo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $223.76 | 2019-2022 | |
| Almirall LLC | $212.69 | 2019-2024 | Klisyri, Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $198.77 | 2019-2025 | Siliq, Cabtreo, Jublia |
| Merz North America, INC. | $188.01 | 2019-2023 | |
| Prugen, INC. Pharmaceuticals | $139.53 | 2019-2020 | |
| Organon LLC | $132.00 | 2025 | Vtama |
| Sanofi-Aventis U.S. LLC | $99.00 | 2022 | |
| Journey Medical Corporation | $91.61 | 2019-2023 | |
| Amgen INC. | $79.90 | 2021-2023 | Otezla |
| Botanix Sb INC | $72.28 | 2025 | Sofdra |
| Dermira, INC. | $67.90 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.23 | 2022-2023 | Spevigo |
| Biofrontera INC. | $34.25 | 2019 | |
| Sanofi US Services INC. | $27.64 | 2023 | |
| Sanofi Pasteur INC. | $24.70 | 2024 | |
| Kyowa Kirin, INC. | $22.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.